The largest database of trusted experimental protocols

Aspergillus fumigatus

Sourced in United States

Aspergillus fumigatus is a fungal strain maintained by the American Type Culture Collection. It is a common airborne saprophytic fungus that can cause various human and animal diseases. The strain is available for laboratory research and analysis purposes.

Automatically generated - may contain errors

22 protocols using aspergillus fumigatus

1

Antimicrobial Activity Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Microdilution method was used to evaluate antibacterial and anti-fungal properties of the extracts following methods described in our earlier study [16 (link)]. Staphylococcus aureus (ATCC (American Type Culture Collection, Manassas, VA, USA) 6538), Listeria monocytogenes (NCTC 7973), and Bacillus cereus (clinical isolate) were used as Gram-positive bacteria. Salmonella typhimurium (ATCC 13311), Pseudomonas aeruginosa (ATCC 27853), Enterobacter cloacae (human isolate), and Escherichia coli (ATCC 35210) were used as Gram-negative bacteria.
Fungi, namely, Aspergillus fumigatus (human isolate), Aspergillus ochraceus (ATCC 12066), Aspergillus niger (ATCC 6275), Aspergillus versicolor (ATCC 11730), Trichoderma viride (IAM 5061), Penicillium funiculosum (ATCC 36839), Penicillium ochrochloron (ATCC 9112) and Penicillium verrucosum var. cyclopium (food isolate), were used to investigate the anti-fungal properties of the extracts.
Anti-microbial results were evaluated by minimum inhibitory (MIC) and minimum bactericidal/fungicidal (MBC/MFC) concentrations. Ampicillin and Streptomycin were used as standards for antibacterial activity. Bifonazole and ketoconazole were used as positive controls for anti-fungal evaluation.
+ Open protocol
+ Expand
2

Microbial Strain Acquisition and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
In the current research, all solvents used were of analytical grade and were supplied by Thermo Scientific (Illkirch, France). All reagents and standards were bought from Merck (Saint-Quentin-Fallavier, Lyon, France). Strains including Bacillus subtilis (ATCC 6633), Klebsiella pneumoniae (ATCC 13883), Staphylococcus epidermidis (ATCC 14490), Pseudomonas aeruginosa (ATCC 9721), Escherichia coli (ATCC 15224), Aspergillus flavus (ATCC 9643), Aspergillus fumigatus (FCBP 66), Fusarium solani (FCBP 434), Aspergillus niger (ATCC 1015) and Mucor species (FCBP 300) were acquired from Department of Biotechnology, QAU, Pakistan.
+ Open protocol
+ Expand
3

Onychomycosis Toenail Sampling Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Scrapings of the toenail plate (1–5 mm2) were obtained from patients with clinical onychomycosis. A total of 534 samples were analyzed from 216 subjects from Brazil (n = 54), Canada (n = 125) and Israel (n = 37). If a dermatophyte was identified then a repeat sample was not required; however, if an NDM was identified then one or more repeat samples were obtained. The following organisms were used as reference strains: Acremonium spinosum (American Type Culture Collection (ATCC) 9471, Manassas, VA, USA), Aspergillus fumigatus (ATCC KM8001), Fusarium oxysporum (ATCC 26225), Microsporum audouinii (Clinical isolate, Mediprobe Research, Inc., London, ON, Canada), Microsporum canis (ATCC 32507), Scopulariopsis brevicaulis (ATCC 52175), Neoscytalidium dimidiatum (ATCC 46921), Trichophyton mentagrophytes (ATCC MYA-4439), Trichophyton rubrum (ATCC MYA-4438), and Trichophyton tonsurans (ATCC 10217).
+ Open protocol
+ Expand
4

Antimicrobial Activity Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibacterial activity was evaluated according to procedures previously described by [19 (link)] using three Gram-positive bacteria Bacillus cereus (human isolate), Staphylococcus aureus (ATCC 11632), and Listeria monicytogenes (NCTC 7973) and three Gram-negative bacteria Escherichia coli (ATCC 35210), Pseudomonas aeruginosa (ATCC 27853), and Salmonella typhimurium (ATCC 13311). The minimum inhibitory concentration (MIC) and minimum bactericidal (MBC) concentration were determined, and streptomycin and ampicillin were used as positive controls. On the other hand, the antifungal activity was evaluated following the protocol described by [44 (link)], using Aspergillus fumigatus (ATCC 1022), Aspergillus versicolor (ATCC 11730), Aspergillus niger (ATCC 6275), Penicillium funiculosum (ATCC 36839), Penicillium ochrachloron (ATCC 9112), and Penicillium verrucosum var. cyclopium (food isolate). The MIC and minimum fungicidal concentration (MFC) were determined. Ketokonazole and bifonazole were used as positive controls. The microorganisms were purchased at the Mycology Laboratory of the Department of Plant Physiology of the Institute for Biological Research “Siniša Stanković” at the University of Belgrade, Serbia.
+ Open protocol
+ Expand
5

Antifungal Evaluation: Microdilution Broth Method

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antifungal evaluation was performed using a microdilution broth method [29 (link)] against eight fungal strains from the Czech Collection of Microorganisms (CCM) (Candida albicans CCM 8320 (ATCC 24433), C. krusei CCM 8271 (ATCC 6258), C. parapsilosis CCM 8260 (ATCC 22019), C. tropicalis CCM 8264 (ATCC 750), Aspergillus flavus CCM 8363, Absidia/Lichtheimia corymbifera CCM 8077 and Trichophyton interdigitale CCM 8377 (ATCC 9533) or the American Type Collection Cultures (ATCC, Mannasas, VA, USA) (Aspergillus fumigatus ATCC 204305). Compounds were dissolved in DMSO and diluted in a twofold manner with RPMI 1640 medium, with glutamine and 2% glucose, buffered to pH 7.0 (3-morpholinopropane-1-sulfonic acid). The final concentration of DMSO in the tested medium did not exceed 2.5% (v/v) of the total solution composition. Static incubation was performed in the dark and in humid atmosphere, at 35 °C, for 24 and 48 h (72 and 120 h for Trichophyton interdigitale respectively). Drug-free controls were included. MIC was inspected visually or making use of Alamar Blue staining. The standards were amphotericin B and fluconazole. All experiments were conducted in duplicate. For the results to be valid, the difference in MIC for one compound determined from two parallel measurements must not be greater than one step on the dilution scale.
+ Open protocol
+ Expand
6

Antimicrobial Activities of Botanical Extracts

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibacterial and antifungal activities of the extracts were determined according to methods described in detail by Pires et al. (2018) [35 (link)] and Heleno et al. (2013) [46 (link)], respectively. Five Gram-negative bacteria (Enterobacter cloacae—ATCC 49741, Escherichia coli—ATCC 25922, Pseudomonas aeruginosa—ATCC 9027, Salmonella enterica—ATCC 13076, and Yersinia enterocolitica—ATCC 8610) and three Gram-positive bacteria (Bacillus cereus—ATCC 11778, Listeria monocytogenes—ATCC 19111 and Staphylococcus aureus—ATCC 25923), besides two fungi strains (Aspergillus fumigatus—ATCC 204305 and Aspergillus brasiliensis—ATCC 16404) purchased from Frilabo (Porto, Portugal) were used. All work was performed with sterile materials handled under laminar flow. Prior to the assays, microorganisms were incubated (37 °C ± 0.5 °C for 24 h for bacteria and 25 °C ± 0.5 °C for 72 h for fungi) with appropriate media for each strain to reach a state of exponential growth. Negative controls of the extract and culture medium were prepared, and the antibiotics streptomycin, methicillin, ampicillin and antifungal ketoconazole served as positive controls. The antimicrobial potential was assessed as the minimum concentration required to inhibit the microorganism growth (MIB) and to cause bacteria or fungi death (MBC or MFC, respectively).
+ Open protocol
+ Expand
7

Antibacterial and Antifungal Activities of Thiazolidinones

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibacterial activity of thiazolidinone derivatives was tested against human pathogenic bacteria, including the Gram-negative bacteria: Escherichia coli (ATCC 35210), Enterobacter cloacae, Pseudomonas aeruginosa (ATCC 27853), Salmonella typhimurium (ATCC 13311), and the Gram-positive bacteria: Listeria monocytogenes (NCTC 7973), Bacillus cereus (clinical isolate), Micrococcus flavus (ATCC 10240), and Staphylococcus aureus (ATCC 6538). In addition, eight fungi species were used for the evaluation of compounds’ antifungal activity, including Aspergillus niger (ATCC 6275), Aspergillus ochraceus (ATCC 12066), Aspergillus fumigatus (ATCC 1022), Aspergillus versicolor (ATCC 11730), Penicillium funiculosum (ATCC 36839), Penicillium ochrochloron (ATCC 9112), Penicillium verrucosum var. cyclopium (food isolate), Trichoderma viride (IAM 5061), and Candida albicans (human isolate). The aforementioned bioassays as well as the resulted minimum inhibitory, minimum bactericidal, and minimum fungicidal concentrations have been reported in our previous paper [18 (link)].
+ Open protocol
+ Expand
8

Antimicrobial Activity Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Different microorganisms including Gram-negative bacteria; Escherichia coli (RCMB 010056), Klebsiella pneumonia (RCMB 0010093), Proteous vulgaris (RCMB 010085), Pseudomonas aeruginosa (RCMB 0100243-5), and Salmonella typhimurium(RCMB 006 (1) ATCC 14028), Gram-positive bacteria; Bacillus subtilis(RCMB 015 (1) NRRL B-543), Staphylococcus epidermidis (RCMB 010027), Streptococcus mutans (RCMB 0100172), Streptococcus pneumoniae (RCMB 0100170-3), Stroptococcus pyogenes (RCMB 0100174-2) and; and fungal strains; Aspergillus fumigatus (RCMB 02568), Candida albicans (RCMB 05036), C. tropicalis (RCMB 05239), Geotricum candidum (RCMB 05097), and Syncephalastrum racemosum (RCMB 09041) were obtained from the Microbiology Laboratory, Regional Center for Mycology and Biotechnology, Al-Azhar University, Cairo, Egypt and used as test organisms.
+ Open protocol
+ Expand
9

Antimicrobial Activity Screening Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Several strains were used in the research: bacteria – Bacillus sp. (ATCC 51912), Enterobacter aerogenes (ATCC 29009), Enterococcus faecalis (ATCC 33186), Escherichia coli (ATCC 25922), Haemophilus influenzae (DSM 4690), Neisseria meningitidis (ATCC 53414), Proteus mirabilis (DSM 4479), Pseudomonas aeruginosa (DSM 13626), Serratia marcescens (DSM 50904), Staphylococcus aureus (ATCC 33497), Staphylococcus epidermidis (ATCC 35983), Staphylococcus haemolyticus (DSM 20263), Streptococcus agalactiae (DSM 2134), Streptococcus pneumoniae (ATCC 49619), Streptococcus pyogenes (DSM 20565), Streptococcus salivarius (DSM 20617), fungi – Aspergillus fumigatus (ATCC 14110), Candida albicans (ATCC 10231), Candida glabrata (DSM 11950), Candida parapsilosis (DSM 5784), Candida tropicalis (ATCC 20115).
+ Open protocol
+ Expand
10

Antibacterial and Antifungal Assay Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
The bacteria and fungi used in this study were chosen primarily on the basis of their importance as opportunistic pathogens of humans infected with TB.[12 22 24 (link)] Strains from the American Type Culture Collection (ATCC) were used for both assays. The bacteria used include four Gram-positive and Gram-negative bacteria, namely, Staphylococcus aureus ATCC 29213, Bacillus cereus ATCC 10702, Enterococcus faecalis ATCC 29212, Streptococcus pyogenes, Pseudomonas aeruginosa ATCC 27853, Klebsiella pneumoniae ATCC 100031, Escherichia coli ATCC 8739, and Salmonella typhimurium ATCC 13311.
For the antifungal analysis, the fungal strains used include Candida albicans ATCC 10231, Aspergillus fumigatus ATCC 204305, and Aspergillus niger ATCC 16888. Mueller-Hinton Agar (MHA), Mueller Hinton Broth (MHB), Sabouraud Dextrose Broth (SDB), and Sabouraud Dextrose Agar (SDA) used were obtained from BioLab and were prepared according to the manufacturer's instructions.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!